ImmunoGen
Executive Summary
President and chief operating officer Donald McCarren resigns effective May 20 to "explore other opportunities in the biotechnology and pharmaceutical industries." His duties will be assumed by Chairman and CEO Mitchel Sayare and other members of the senior management team, ImmunoGen says